Tu Salud News Update FDA Approves Two Hepatitis C Treatments for Younger Children The Epclusa and Mavyret combination pills are now indicated for kids as young as age 3. Advertisement Honor International NASH Day 2021—Your Liver Will Thank You! NASH is a more severe form of non-alcoholic fatty liver disease. Learn more about this type of hepatitis on #NASHday 2021. First KRAS-Blocking Drug Approved for Advanced Lung Cancer Lumakras led to tumor shrinkage in 36% of NSCLC patients with KRAS G12C mutations. Exploring LGBTQ Sexual Health Two LGBTQ people share how they get their sexual health needs met. Healthy Mind Please tell Tu Salud about your mental health by completing this survey. Tu Salud Archives Read previous issues of Tu Salud magazine. Newsfeed CDC Reports Rare Breakthrough COVID Cases Among Fully Vaccinated FDA Approves Two Hepatitis C Treatments for Younger Children Honor International NASH Day 2021—Your Liver Will Thank You! Southern Health Centers Unite for $9.8M to Study Latino Cancer Survivorship Features COVID Vaccine Disparities Worsen Even as Supply Outstrips Demand Explorando la salud sexual de las personas LGBTQ Exploring LGBTQ Sexual Health Corporations Encourage Employee COVID Vaccination but Stop Short of Mandates Newsfeed CDC Reports Rare Breakthrough COVID Cases Among Fully Vaccinated FDA Approves Two Hepatitis C Treatments for Younger Children Honor International NASH Day 2021—Your Liver Will Thank You! Southern Health Centers Unite for $9.8M to Study Latino Cancer Survivorship Features COVID Vaccine Disparities Worsen Even as Supply Outstrips Demand Explorando la salud sexual de las personas LGBTQ Exploring LGBTQ Sexual Health Corporations Encourage Employee COVID Vaccination but Stop Short of Mandates

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@tusaludmag.com. Please remember to add update@tusaludmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: